Health Care • Medical/Dental Instruments
$14.04 ▼ -0.60
(-4.10%)
MKT CAP: $487.2M • VOL: 427.4K
52W L $8 52W H $17
DCTH // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $85.2M | $37.2M | $2.1M |
| YoY Revenue Growth % | +129.1% | +1701.7% | — |
| Gross Profit | $73.4M | $31.0M | — |
| Gross Margin % | 86.2% | 83.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $660.0K | -$12.4M | -$38.2M |
| Operating Margin % | 0.8% | -33.4% | -80.0% |
| Net Income (GAAP) | $2.7M | -$26.4M | -$47.7M |
| EBITDA (Normalized) | $1.9M | -$12.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $22.5M | -$18.7M | -$31.3M |
| Capital Expenditures (CapEx) | $1.5M | $559.0K | — |
| Free Cash Flow (FCF) | $21.0M | -$19.2M | -$31.3M |
| FCF Margin % | 24.6% | -51.7% | -80.0% |
| Return on Invested Capital (ROIC %) | 0.8% | -27.0% | — |
| Cash & Short-Term Equivalents | $43.5M | $32.4M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $111.2M | $68.7M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR DCTH.